CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

KRROKorro Bio, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $9.91 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$145.93M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-15 · FORMELA JEAN FRANCOIS (Director) · SELL
  • 2026-09-14 · Dolan Oliver (Senior Vice President, Finance) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders116
Shares held15,855,562
Value$230.01M
Percent of shares outstanding107.67%
As of quarter end2026-06-30
RECENT NEWS
  • H.C. Wainwright reiterates Korro Bio stock rating on trial dosing
  • KRRO: Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121
  • Korro Bio grants non-statutory stock options to three newly hired employees
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Korro Bio, Inc. (KRRO) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit